Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | CMPS COMPASS Pathways Plc - American Depository | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $15.19 +1.3% | $15.06 -2.0% |
| StockIQ Score | 60C+ Moderate Risk: High | 35F Weak Risk: High |
| Technical | 91A+ | 13F |
| Fundamental | 48D+ | 35F |
| Growth | 38F | 50C- |
| Fair Value | 50C- | 38F |
| News | 74B | 50C- |
| Quality | 55C | 50C- |
| Risk | 32F | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
COMPASS Pathways (CMPS) outperforms Ascentage Pharma (AAPG) in most categories. Its investor score (54 vs. 37) and technical score (66 vs. 18) are significantly higher, showing stronger market sentiment and trading performance. CMPS also has a moderate rating, while AAPG is rated weak. AAPG only leads in growth (50 vs. 38), but the gap isn’t large.